- Home
- RARE vs AAUC Comparison
RARE vs AAUC Comparison
Compare RARE & AAUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RARE | AAUC |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.8B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | RARE | AAUC |
|---|---|---|
| Price | $34.13 | $24.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $85.20 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 793.4K |
| Earning Date | 02-12-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $630,598,000.00 | ★ $1,074,850,000.00 |
| Revenue This Year | $19.09 | $80.32 |
| Revenue Next Year | $20.62 | $54.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 20.63 | ★ 45.41 |
| 52 Week Low | $25.81 | $6.84 |
| 52 Week High | $46.50 | $25.00 |
Technical Indicators
Market Signals| Indicator | RARE | AAUC |
|---|---|---|
| Relative Strength Index (RSI) | 49.54 | 75.37 |
| Support Level | $32.64 | $22.32 |
| Resistance Level | $35.12 | $23.82 |
| Average True Range (ATR) | 1.44 | 0.90 |
| MACD | -0.27 | 0.15 |
| Stochastic Oscillator | 22.07 | 94.37 |
Price Performance
Historical ComparisonAbout RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About AAUC Allied Gold Corporation
Allied Gold Corp is a company focused on gold mining activities in Africa. Allied has three mines and several development and exploration projects in Africa where it has operating experience. Operations are located in Cote d'Ivoire, Mali, and Ethiopia. The company expands and optimizes initiatives at existing operating mines, the development of new mines, the advancement of its exploration properties, and, targeting other consolidation opportunities with a focus on Africa.